date:May 24, 2012
e high prevalence of comorbid conditions associated with AD/HD, the results are intriguing and provide reason to believe that supplementation with the long-chain O3 fatty acids may be beneficial for some children diagnosed with AD/HD.
I would argue, however, that the impact may have nothing to do with the AD/HD, rather the comorbid conditions. That, however, is a discussion for another day.
Study details
Led by Dr Natalie Parletta, the researchers recruited 90 children with ADHD aged betwe